NO EN
Enter at least 3 characters
news.png
HOME > News & press releases > Nyheter og pressemeldinger
print.png
email.png

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Tillat behandling av personopplysninger.

Nyheter og pressemeldinger

 
Ny EMA-godkjenning ved behandling av Fabrys sykdom
  Pressemelding, Stockholm, 10th of March 2026   "Ny EMA-godkjenning ved behandling av Fabrys...
btnaree.png
1/9
Chiesi Carbon Minimal Inhalers reach new milestone with clinical phase III initiation
2/9
Chiesi and Karolinska Institutet (KI) Forge Strategic Research Alliance to Advance Precision Medicine for Patients with Lung Disease
3/9
ARCHIVE NYHETER AND PRESSMELDINGER
Febrary 2026
05 February
Chiesi har mottatt en positiv uttalelse fra CHMP for behandling av Fabrys sykdom med...
btnboxnews.png
October 2024
30 October
Chiesi har lansert en ny KOLS nettside rettet mot pasienter
btnboxnews.png
Juny 2020
08 June
Chiesi Nordics supports employees, patients and caregivers during the Covid-19 pandemic
btnboxnews.png
April 2020
28 April
Rengjøring av AeroChamber Flow-Vu
btnboxnews.png
March 2020
30 March
Chiesi Group increases support measures and announces new funds for employees, patients and...
btnboxnews.png
Febrary 2020
06 February
Chiesi Group Announces Establishment of New Global Rare Diseases Division
btnboxnews.png
Dicember 2019
04 December
Chiesi investerar 350 miljoner EURO i den första koldioxidsnåla sprayinhalatorn för astma och KOL
btnboxnews.png
September 2016
02 September
The Lancet publishes the results of Chiesi Farmaceutici TRILOGY study
btnboxnews.png
Febrary 2016
15 February
Chiesi is Top Employers again!
btnboxnews.png
November 2015
30 November
Alberto, Paolo and Andrea Chiesi winners of the “Entrepreneur of the year 2015” Award
btnboxnews.png
© 2026 Chiesi Pharma AB
Klara Norra kyrkogata 34, 111 22 Stockholm
Telefon +46 8 753 35 20
E-post infonordic@chiesi.com

Denne siden er oppdatert 28/05/2018
CHIESI PÅ INTERNETT
mappa.png